Related Experiment Videos
[A case of lymphoid interstitial pneumonia]
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunohistochemical demonstration of epidermal growth-factor receptors in normal, benign and malignant thyroid tissues.
International journal of oncology·2011
Reentrant spin-glass transition in a dilute magnet.
Physical review letters·2005
[Lung cancer with ground glass opacity diagnosed by transbronchial lung biopsy using an ultrathin bronchoscope and virtual bronchoscopy].
Kyobu geka. The Japanese journal of thoracic surgery·2004
Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Lipomatous change in a brain metastasis from malignant pleural mesothelioma.
Neuroradiology·2001
Expression of p8 in human pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
[A case of expanding pulmonary aspergilloma].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[A case of allergic bronchopulmonary aspergillosis caused by Aspergillus terreus].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[Pulmonary thromboembolism associated with antiphospholipid syndrome in scleroderma].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[Clinical investigation of three cases of pulmonary eosinophilic granuloma].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[A case of primary acute pulmonary cavitation in sarcoidosis complicated by multiple nodular lesions in the central nervous system].
Nihon Kyobu Shikkan Gakkai zasshi·1998
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026